Betaville Intelligence

UNCOOKED ALERT: Clinigen said to ...

Clinigen, an Aim-listed medical supplies company, has come under the spotlight amid takeover talk.

People following the situation said a potential acquirer is eyeing the company, which supplies drugs for clinical trials and also distributes unlicensed pharmaceuticals to pharmacists.

One person following the situation suggested purchaser could be a private equity firm.

Clinigen has grown through a series of acquisitions since it listed on the Aim market in 2012 at 164p...

Register

Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Thursday, 4 June 2020, 3:57 pm

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation